0
Skip to Content
Celea Therapeutics
Deupirfenidone
Patients & Physicians
About Us
News
Contact Us
Celea Therapeutics
Deupirfenidone
Patients & Physicians
About Us
News
Contact Us
Deupirfenidone
Patients & Physicians
About Us
News
Contact Us
Sven Dethlefs, PhD
Jamison Wright 6/9/26 Jamison Wright 6/9/26

Sven Dethlefs, PhD

Chief Executive Officer

Read More
David Golod, PhD, MBA
Jamison Wright 6/9/26 Jamison Wright 6/9/26

David Golod, PhD, MBA

Clinical Operations & Program Strategy

Read More
Camilla Graham, MD, MPH
Jamison Wright 6/9/26 Jamison Wright 6/9/26

Camilla Graham, MD, MPH

Medical Affairs

Read More
Neera Jain, PhD, MBA
Jamison Wright 6/8/26 Jamison Wright 6/8/26

Neera Jain, PhD, MBA

Chemistry, Manufacturing, and Controls

Read More

Celea Therapeutics

6 Tide Street, Suite 400
Boston, MA 02210


info@celeatx.com

DEUPIRFENIDONE
PATIENTS & PHYSICIANS
ABOUT US
NEWS & PUBLICATIONS
CONTACT

© 2026 Celea Therapeutics, Inc. All rights reserved. Expanded Access Policy

The FDA and corresponding regulatory authorities will ultimately review our clinical results and determine whether deupirfenidone is safe and effective. No regulatory agency has made any such determination that deupirfenidone is safe or effective for use by the general public for any indication.